Erste Asset Management’s Pacira BioSciences PCRX Stock Holding History

Erste Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,800	Closed	-$329K	–	565
2023 Q4	$329K	Hold	9,800	–	–	﹤0.01%	456
2023 Q3	$302K	Hold	9,800	–	–	0.01%	453
2023 Q2	$387K	Hold	9,800	–	–	0.01%	444
2023 Q1	$394K	Hold	9,800	–	–	0.01%	446
2022 Q4	$382K	Hold	9,800	–	–	0.01%	445
2022 Q3	$532K	Hold	9,800	–	–	0.01%	418
2022 Q2	$575K	Hold	9,800	–	–	0.01%	415
2022 Q1	$742K	Sell	9,800 -4,600	-32%	-$307K	0.01%	389
2021 Q4	$896K	Hold	14,400	–	–	0.02%	366
2021 Q3	$817K	Hold	14,400	–	–	0.02%	355
2021 Q2	$874K	Hold	14,400	–	–	0.02%	357
2021 Q1	$1.02M	Hold	14,400	–	–	0.03%	334
2020 Q4	$852K	Hold	14,400	–	–	0.02%	350
2020 Q3	$855K	Hold	14,400	–	–	0.03%	311
2020 Q2	$749K	Hold	14,400	–	–	0.03%	312
2020 Q1	$485K	Hold	14,400	–	–	0.03%	309
2019 Q4	$642K	Hold	14,400	–	–	0.03%	312
2019 Q3	$576K	Hold	14,400	–	–	0.03%	314
2019 Q2	$633K	Hold	14,400	–	–	0.03%	294
2019 Q1	$549K	Hold	14,400	–	–	0.03%	307
2018 Q4	$599K	Buy	+14,400	New	+$672K	0.04%	283

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Erste Asset Management's PCRX Position: Q1 2024 in Review

Erste Asset Management sold out of Pacira BioSciences (PCRX) in Q1 2024, closing a stake of 9,800 shares — an estimated $329K sold.

Erste Asset Management first reported a position in PCRX in Q4 2018 and held it in 21 quarters. The position peaked at $1.02M in Q1 2021. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2024.

Erste Asset Management reported no remaining Pacira BioSciences position as of Q1 2024 after selling out during the quarter.
Erste Asset Management sold 9,800 Pacira BioSciences shares in Q1 2024, an estimated $329K.
Erste Asset Management first reported a position in Pacira BioSciences in Q4 2018 and held it in 21 quarters.
Erste Asset Management's Pacira BioSciences position peaked at $1.02M in Q1 2021.
270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.